Results 161 to 170 of about 7,354,999 (259)

Allergic Rhinitis Amplifies Asthma Risk in Patients With Chronic Rhinosinusitis: A Large‐Scale Retrospective Cohort Analysis

International Forum of Allergy &Rhinology, Volume 16, Issue 9, Page 931-941, September 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) are two highly prevalent airway diseases in the United States. While the coexistence of CRS and asthma is well recognized, less is known about the development of new‐onset asthma in CRS, particularly in the context of comorbid AR. This study assessed the impact of CRS and AR on
Austin J. Lee, Mohamad R. Chaaban
wiley   +1 more source

Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes. [PDF]

Turk J Med Sci
Çelebi Çelik F, Kazancioğlu A, Günder S, Ocak M, Uzunoğlu B, Karkiner CŞ, Sancakli Ö, Tuncer A, Uysal Soyer Ö, Şekerel BE, Can D, Şahiner ÜM.   +11 more
europepmc   +1 more source

Attenuation of allergen-specific immunotherapy for atopic dermatitis by ectopic colonization of Brevundimonas vesicularis in the intestine. [PDF]

Cell Rep Med, 2023
Liu X, Xu B, Xu X, Wang Z, Luo Y, Gao Y, Ling S, Wang A, Zhou Y, Wang X, Leng SX, Li W, Yao X.   +12 more
europepmc   +1 more source

Allergen-specific immunotherapy in rhinitis patients is associated with milder COVID-19 symptoms and improved quality of life. [PDF]

Clinics (Sao Paulo)
Li H, Wang R, Yu B, He J, Hu Y, Xie Z, Xiao Z.   +6 more
europepmc   +1 more source

Safety of allergen-specific immunotherapy in children. [PDF]

Pediatr Allergy Immunol, 2022
De Filippo M, Votto M, Caminiti L, Panasiti I, Carella F, De Castro G, Landi M, Olcese R, Vernich M, Marseglia GL, Ciprandi G, Barberi S.   +11 more
europepmc   +1 more source

Natural Compounds Targeting Oncogenic Signaling Networks in Glioblastoma: Molecular Mechanisms, Translational Advances, and Clinical Perspectives

Brain and Behavior, Volume 16, Issue 9, September 2026.
Glioblastoma (GBM) is a highly aggressive brain tumor with a poor prognosis, driven by abnormal signaling pathways that promote growth and resistance to treatment. Conventional therapies are inadequate, highlighting the need for novel multitargeted approaches.
Mehrukh Zehravi, Md Abul Hassan, Md. Al Amin, Sherouk Hussein Sweilam, Jeetendra Kumar Gupta, Ramenani Hari Babu, Pericharla Venkata Narasimha Raju, Krishna Vamsi Kandimalla, Phanindra Erukulla, Patibandla Jahnavi, Rajeshwar Vodeti, Abdul Ajeed Mohathasim Billah, Safia Obaidur Rab, Sharuk L. Khan   +13 more
wiley   +1 more source

Next-Generation Allergen-Specific Immunotherapy for Food Allergy. [PDF]

Clin Rev Allergy Immunol
Lee JZX, Sit JKC, Leung NYH, Chu KH, Leung PSC, Leung TF, Wai CYY.   +6 more
europepmc   +1 more source

Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis. [PDF]

Allergol Select, 2023
Worm M, Pfaar O.
europepmc   +1 more source

Resveratrol Ameliorates Allergic Rhinitis by Activating SIRT1 to Disrupt the Mitochondrial ROS‐Inflammation Vicious Cycle

Flavour and Fragrance Journal, Volume 41, Issue 5, Page 1187-1200, September 2026.
This study demonstrates that resveratrol alleviates allergic rhinitis by activating SIRT1, thereby disrupting the mitochondrial ROS‐inflammatory cycle, improving mitochondrial function, promoting anti‐inflammatory M2 macrophage polarisation, and reducing epithelial oxidative damage.
Xinyu Zhou, Yi Yue, Wenwen Qi, Wenqing Zhu, Xinran Liu, Rongcui Sui, Xuanchen Zhou   +6 more
wiley   +1 more source

Prospective Evaluation of Symptom Burden and Medication Use in Seasonal Allergic Rhinitis/Rhinoconjunctivitis Patients Considering Allergen-Specific Immunotherapy. [PDF]

J Clin Med
Rybachuk A, Neuhof C, Curtius E, Acikel C, Fragel S, Sahin H, Katzke N, Shah-Hosseini K, Allekotte S, Raskopf E.   +9 more
europepmc   +1 more source